- Zacks•1 hour ago
Vertex Pharmaceuticals (VRTX) has seen positive earnings estimate revisions for the current quarter and year, in addition to decent short-term price momentum.
- Motley Fool•yesterday
Slowing sales growth for its rare-disease drugs kept the market second-guessing the biotech's potential.
- Zacks•6 days ago
Merck (MKGAF) and Vertex (VRTX) collaborated for the development and commercialization of four research and development programs for the treatment of cancer.
VRTX : Summary for Vertex Pharmaceuticals Incorpor - Yahoo Finance
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||81.15 x 100|
|Ask||82.99 x 400|
|Day's Range||81.58 - 82.87|
|52 Week Range||71.46 - 103.73|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-72.56|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|